These are Biotech momentum after their earnings reports. earnings report.
#NTRP phase 2 data Alzheimer's study before market open. Watch BIIB, AVXL reaction #AEZS Phase 3 data Monday http://finance.yahoo.com/news/aeterna-zentaris-announce-top-line-210000276.html These are biotech long setup ideas
IBB chart below is outdated, the target bounce for the bounce remains the same on 280/290 range.(don't expect on no pullback/going straight outright to the target) new support for IBB is 255 for the momentum to stick.
2016 has been a year of extremities so far. As SPY & global started the year for relentless selling, gloom & doom headlines & then comes the relentless bounce taking SPY from -12% to meager +.25% YTD in span of 5 trading weeks. While most indixes/sectors has bounced. IBB has been leftout, once darling for [...]
*** This is not an investment advice**** We are not a research firm to provide members with in depth research analyst, we trade based on catalyst, make money and move on to the next. With biotech, I find no matter how in depth due diligence you do there is always a risky side. Be nibble [...]
$IBB has shown relative weakness for second day in the row, notably few biotechs has had uphold trendline (up) which means found buyers support. Make no mistake, the list below remains a follower of IBB, they wont be immune on any further sell off. However, keep them close on watchlist as if the sector [...]